PARIS (Reuters) – The head of Sanofi in France, Olivier Bogillot, said on Saturday that his future COVID-19 vaccine would likely cost less than 10 euros per injection.
“The price is not totally fixed… We are evaluating the production costs for the coming months… We will be below 10 euros,” Bogillot told France Inter radio.
Drugmakers and government agencies around the world are fighting to fight the pandemic and develop vaccines and treatments for COVID-19.
Asked about his rival AstraZeneca, who is expected to price his shot at around 2.50 euros in Europe, Bogillot said:
“The price differential for us may be that we are using all of our internal resources, our own researchers, our own research centers. AstraZeneca outsources part of its production ”,
Earlier this week, Sanofi and Britain’s GlaxoSmithKline said they had started a clinical trial of their protein-based COVID-19 vaccine candidate and aimed to reach the final phase of testing by December.
If the results are conclusive, Sanofi and GSK hope to get the vaccine approved in the first half of next year.
Reporting by Dominique Vidalon; Editing by Frances Kerry
Our standards:Thomson Reuters Trust Principles.